Trademark Search in Canada

SKYHAWK

View On IC.GC.CA

REGISTERED

on 27 Dec 2024

Last Applicant/ Owned by

Skyhawk Therapeutics, Inc.

180 3rd Avenue, Fifth Floor,Waltham, MA 02451

Serial Number

2077075 filed on 13^th Jan 2021

Registration Number

TMA1278584 registered on 27^th Dec 2024

Registration expiry Date

27^th Dec 2034

Correspondent Address

BCF S.E.N.C.R.L./BCF LLP

1100, boul. René-Lévesque Ouest25e ÉtageMontréal

QUÉBEC

H3B5C9

SKYHAWK

Trademark usage description

pharmaceuticals, namely, small molecule therapeutic preparations for the correction of rna expression and alteration of rna translation, used in the t Read More

Classification Information

Class [005]
Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of cancers, neurological diseases, and other diseases.

Classification kind code

Class [042]
Research and development of pharmaceuticals, namely, small molecule therapies for the correction of RNA expression and alteration of RNA translation, used in the treatment of cancers, neurological diseases, and other diseases.

Classification kind code

Mark Details

Serial Number

2077075

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 9^th Oct 2024	Advertised
Submitted for opposition 27 on 11^th Sept 2024	Approval Notice Sent
Submitted for opposition 26 on 11^th Sept 2024	Approved
Submitted for opposition 22 on 3^rd Sept 2024	Search Recorded
Submitted for opposition 135 on 22^nd Feb 2024	Amendment to Application
Submitted for opposition 135 on 10^th Jan 2024	Amendment to Application
Submitted for opposition 287 on 27^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 13^th Jan 2021	Filed
Submitted for opposition 1 on 13^th Jan 2021	Created
Submitted for opposition 31 on 13^th Jan 2021	Formalized

SKYHAWK

Classification Information

Class [005]Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of cancers, neurological diseases, and other diseases.

Classification kind code

Class [042]Research and development of pharmaceuticals, namely, small molecule therapies for the correction of RNA expression and alteration of RNA translation, used in the treatment of cancers, neurological diseases, and other diseases.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of cancers, neurological diseases, and other diseases.

Class [042]
Research and development of pharmaceuticals, namely, small molecule therapies for the correction of RNA expression and alteration of RNA translation, used in the treatment of cancers, neurological diseases, and other diseases.